Pogatzki-Zahn Esther M, Zahn Peter K
Klinik und Poliklinik für Anästhesiologie und operative Intensivmedizin des Univklinikums Münster, Germany.
Anasthesiol Intensivmed Notfallmed Schmerzther. 2007 Jan;42(1):22-31. doi: 10.1055/s-2007-969041.
Postoperative pain is now a critical focus of perioperative patient care. The current perioperative analgesic strategy is a "balanced-multimodal analgesia". Cornerstones of this treatment approach are patient controlled neuraxial administration of local anesthetics and opioids or patient controlled intravenous administration of opioids. However, systemic opioids are limited by side effects. Thus, adjuvants like anticonvulsants, NMDA receptor antagonists, alpha-2 adrenergic agonists and other non-Opioid analgesics are considered to reduce pain and opioid requirements in the perioperative period. In the present review we discuss recent findings about the effectiveness of different systemic administered adjuvants including ketamine, lidocaine, gabapentin, pregabalin and corticosteroids for postoperative pain treatment. Furthermore a nurse based oral analgesic concept using controlled released Oxycodon for all postoperative patients without a patient controlled analgesia device will be introduced.
术后疼痛现已成为围手术期患者护理的关键焦点。当前的围手术期镇痛策略是“平衡多模式镇痛”。这种治疗方法的基石是患者自控硬膜外给予局部麻醉药和阿片类药物,或患者自控静脉给予阿片类药物。然而,全身性阿片类药物存在副作用限制。因此,抗惊厥药、NMDA受体拮抗剂、α-2肾上腺素能激动剂和其他非阿片类镇痛药等佐剂被认为可在围手术期减轻疼痛并减少阿片类药物的用量。在本综述中,我们讨论了不同全身性给予的佐剂(包括氯胺酮、利多卡因、加巴喷丁、普瑞巴林和皮质类固醇)用于术后疼痛治疗有效性的最新研究结果。此外,还将介绍一种基于护士的口服镇痛方案,该方案针对所有没有患者自控镇痛设备的术后患者使用控释羟考酮。